XML 39 R27.htm IDEA: XBRL DOCUMENT v3.22.0.1
Note 2 - Summary of Significant Accounting Policies (Details Textual)
12 Months Ended
Sep. 25, 2020
Jan. 21, 2020
Dec. 31, 2021
USD ($)
shares
Dec. 31, 2020
USD ($)
shares
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) | shares     213,831 1,001,948
Research and Development Expense, Total     $ 15,554,171 $ 2,444,459
Upfront Fees for COH and PNP License[Member]        
Research and Development Expense, Total     $ 10,513,825  
Minimum [Member]        
Property, Plant and Equipment, Useful Life (Year)     3 years  
Maximum [Member]        
Property, Plant and Equipment, Useful Life (Year)     5 years  
Reverse Stock Split [Member]        
Stockholders' Equity Note, Stock Split, Conversion Ratio 20 2,000